The pharmaceutical industry is in a state of flux especially in regards to DTC advertising. The Pharmaceutical Research and Manufacturers of America (PHRMA) has issued guiding principles that outline deferment of new product DTC programs to allow attention to physician education and patient experience.
Campaign Booster programs are initiated when a patient responds to a call to action. At this point they are asked a few questions about their condition and provided with a personalized report to bring to their physician. This report is the initiation of a patient – physician communication about the condition, the benefits of your product and the value of continuous treatment feedback.
During treatment Campaign Booster gathers compliance, persistency or relevant quality of life information and delivers personalized reports to each physician concerning their patient.
By increasing the quality of communication between patients and their physicians, better treatment outcomes are possible. Better treatment outcomes build lasting brand loyalty with both patients and physicians. Lasting brand loyalty translates into powerful market share.
Both Treatment Educator and Brand Accelerator can be introduced at any time into a Campaign Booster program.
|
Products & Services
